Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,403,107
  • Shares Outstanding, K 164,986
  • Annual Sales, $ 11,580 K
  • Annual Income, $ -436,370 K
  • 60-Month Beta 1.44
  • Price/Sales 552.95
  • Price/Cash Flow N/A
  • Price/Book 3.83
Trade RVMD with:

Options Overview Details

View History
  • Implied Volatility 61.33% ( +0.24%)
  • Historical Volatility 30.68%
  • IV Percentile 47%
  • IV Rank 12.46%
  • IV High 176.22% on 10/20/23
  • IV Low 44.97% on 08/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 259
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 5,882
  • Open Int (30-Day) 12,859

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.75
  • Number of Estimates 9
  • High Estimate -0.73
  • Low Estimate -0.77
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +18.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.48 +2.47%
on 06/17/24
41.21 -9.28%
on 06/03/24
-0.95 (-2.48%)
since 05/31/24
3-Month
29.55 +26.50%
on 04/05/24
41.21 -9.28%
on 06/03/24
+6.46 (+20.89%)
since 04/02/24
52-Week
15.44 +142.10%
on 10/23/23
41.21 -9.28%
on 06/03/24
+10.63 (+39.74%)
since 06/30/23

Most Recent Stories

More News
Stocks Retreat as Bond Yields Surge on US Price Pressures

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. Stock indexes...

$SPX : 5,509.01 (+0.62%)
SPY : 549.01 (+0.67%)
$DOWI : 39,331.85 (+0.41%)
DIA : 393.29 (+0.47%)
$IUXX : 20,011.89 (+1.01%)
QQQ : 486.98 (+1.05%)
ZNU24 : 109-125 (-0.07%)
DECK : 940.64 (-0.60%)
DHI : 135.21 (-1.32%)
BLDR : 134.74 (+0.56%)
LEN : 143.61 (-1.59%)
PHM : 104.52 (-1.61%)
Stocks Tumble as Sticky US CPI Curbs the Outlook for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.13%. Stock indexes today...

$SPX : 5,509.01 (+0.62%)
SPY : 549.01 (+0.67%)
$DOWI : 39,331.85 (+0.41%)
DIA : 393.29 (+0.47%)
$IUXX : 20,011.89 (+1.01%)
QQQ : 486.98 (+1.05%)
ZNU24 : 109-125 (-0.07%)
DECK : 940.64 (-0.60%)
DHI : 135.21 (-1.32%)
BLDR : 134.74 (+0.56%)
TOL : 111.21 (-1.00%)
LEN : 143.61 (-1.59%)
Stocks Sink as US CPI Tops Forecasts

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.00%. Stock indexes today...

$SPX : 5,509.01 (+0.62%)
SPY : 549.01 (+0.67%)
$DOWI : 39,331.85 (+0.41%)
DIA : 393.29 (+0.47%)
$IUXX : 20,011.89 (+1.01%)
QQQ : 486.98 (+1.05%)
ZNU24 : 109-125 (-0.07%)
DECK : 940.64 (-0.60%)
DHI : 135.21 (-1.32%)
BLDR : 134.74 (+0.56%)
TOL : 111.21 (-1.00%)
LEN : 143.61 (-1.59%)
Why Revolution Medicines Stock Is Crashing Today

Investors were disappointed by Revolution Medicines' data, presented at ESMO.

RVMD : 37.38 (-3.68%)
Why Shares of Revolution Medicines Were Popping on Friday

The company released positive phase 1/1b trial data on two cancer therapies.

RVMD : 37.38 (-3.68%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RETA : 172.36 (+0.02%)
EQRX : 2.34 (-2.09%)
RVMD : 37.38 (-3.68%)
Circle Pharma Appoints Stephen Kelsey, MB ChB, MD, to its Board of Directors

Circle Pharma, a company focused on developing macrocycle therapeutics against targets previously considered to be undruggable, has appointed Stephen Kelsey as an independent member of its Board of Directors....

RVMD : 37.38 (-3.68%)
MRNA : 117.07 (+0.97%)
PFE : 27.83 (-1.38%)
GERN : 4.17 (-3.92%)
Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

First two RAS(ON) Inhibitor drug candidates advance into clinical development Successful equity financing supports development of portfolio of targeted...

RVMD : 37.38 (-3.68%)
Revolution Medicines to Report Financial Results for Second Quarter 2022 After Market Close on August 9, 2022

REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel...

RVMD : 37.38 (-3.68%)
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Underwriters’ full exercise of option brings gross proceeds to $264.5 million...

RVMD : 37.38 (-3.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 40.51
2nd Resistance Point 39.85
1st Resistance Point 38.62
Last Price 37.38
1st Support Level 36.73
2nd Support Level 36.07
3rd Support Level 34.84

See More

52-Week High 41.21
Last Price 37.38
Fibonacci 61.8% 31.36
Fibonacci 50% 28.32
Fibonacci 38.2% 25.28
52-Week Low 15.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar